Atlas Trials

Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications

Clinical trial NCT01518101 · COMPLETED

Trial details

NCT number
NCT01518101
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2012-01-01
Primary completion
2012-10-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.